Exam (elaborations)
NURS 5334 DIABETES MELLITUS CASE STUDY 3
- Course
- Institution
NURS 5334 DIABETES MELLITUS CASE STUDY 3/NURS 5334 DIABETES MELLITUS CASE STUDY 3/NURS 5334 DIABETES MELLITUS CASE STUDY 3
[Show more]
Seller
Follow
Ultimatenurse
Reviews received
Content preview
NURS 5334 DIABETES MELLITUS CASE STUDY 3NURS 5334 DIABETES MELLITUS CASE STUDY 3
Diabetic Case Study
University of Texas Arlington College of Nursing and Health Innovation
Nursing 5334 Advanced Pharmacology for NPs
Lynda Jarrell, DNP, APRN, FNP-BC
, NURS 5334 DIABETES MELLITUS CASE STUDY 3
Assessment:
Patient is a 55 years old female with the symptoms of urinary frequency, urinary
urgency, and burning on urination with the history of urinary tract infection. Patient’s vital
signs are blood pressure 150/90 mm Hg, pulse 72, Ht 5 feet 5 inches, weight 180 lbs.
Furthermore, urinalysis confirms urinary tract infection and shows protein and high
glucose level in the urine. Patient has a random plasma glucose level of 220 mg/dL.
Patient has a family history of type 2 diabetes. Marion’s laboratory findings are as
follows:
• Fasting plasma glucose 180 mg/dL
Total cholesterol 250
• Triglycerides 350 mg/dL
• High-density lipoprotein cholesterol 35 mg/dL
• Low-density lipoprotein cholesterol 164 mg/dL
• HbA1c 7.4%
• Serum creatinine 1.2
• Glomerular filtration rate >60
• Thyroid function studies within normal limits
Based on the collected labs with the presenting symptoms, the assessment of the
patient are diabetes type II, hypertension, hyperlipidemia and obesity.
Plan:
The patient’s treatment plan will include an antihypertensive medication such as
Angiotensin coverting enzyme (ACE) inhibitor or an Angiotensin II receptor blocker
(ARB) to reduce blood pressure along with a statin to address the hyperlipidemia. In
addition, the patient will also require a glucose lowering agent to maintain glycemic
control. Patient education will be provided regarding to life style changes such as weight
loss, diet, diabetes self-management and physical activity. Cardiac risk calculation per
http://www.cvriskcalculator.com is 13.2%
Pharmacologic:
1. Metformin 500 mg by mouth twice a day for diabetes type II
2. Lovastatin 20 mg by mouth daily for hyperlipidemia
3. Lisinopril 10 mg by mouth daily for hypertension
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Ultimatenurse. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $14.99. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
75323 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now